Clinical pharmacology review of safinamide for the treatment of Parkinson's disease.
about
Clinical Pharmacokinetics and Pharmacodynamics of Safinamide.An update on potential therapeutic strategies for Parkinson's disease based on pathogenic mechanisms.Algorithms for the treatment of motor problems in Parkinson's disease.Subnanomolar indazole-5-carboxamide inhibitors of monoamine oxidase B (MAO-B) continued: indications of iron binding, experimental evidence for optimised solubility and brain penetration.Synthesis and Evaluation of Novel α-Aminoamides Containing an Indole Moiety for the Treatment of Neuropathic Pain.
P2860
Clinical pharmacology review of safinamide for the treatment of Parkinson's disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clinical pharmacology review of safinamide for the treatment of Parkinson's disease.
@en
type
label
Clinical pharmacology review of safinamide for the treatment of Parkinson's disease.
@en
prefLabel
Clinical pharmacology review of safinamide for the treatment of Parkinson's disease.
@en
P2093
P2860
P356
P1476
Clinical pharmacology review of safinamide for the treatment of Parkinson's disease
@en
P2093
Daisy Abreu
Joaquim J Ferreira
Mario M Rosa
P2860
P304
P356
10.2217/NMT.15.46
P577
2015-11-20T00:00:00Z